Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach
about
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataMalaria Parasites: The Great EscapeLongitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistancePlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.Identifying artemisinin resistance from parasite clearance half-life data with a simple Shiny web applicationThe clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.Parasite clearance rates in Upper Myanmar indicate a distinctive artemisinin resistance phenotype: a therapeutic efficacy studyArtemisinin-Resistant Plasmodium falciparum Malaria.Use of quantitative pharmacology tools to improve malaria treatments.Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance.Combating multidrug-resistant Plasmodium falciparum malaria.Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border.malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication.Efficacy of Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Cruzeiro do Sul, Brazil, 2016.
P2860
Q26783902-6E6B9B22-4F5E-4394-B33B-CFE00B2B4A90Q28080325-B3CA3027-3DA3-4994-927C-A88B867CE302Q30044965-4826D7F2-D90B-41D5-9433-892A3AA54DD9Q30240158-EA2F434D-7809-4EA2-9FBB-6D4123DEB3B1Q30491741-6288178E-5DF0-44D9-867F-556F06CFFE5FQ33655603-9647F674-8BCC-42D3-B4C8-D8BE022C6EF7Q36749208-07408EEA-B020-45E7-B1E0-750C542538EBQ37193474-BA80170E-8DCC-4035-8317-927E15211440Q38664529-775CB144-2C3C-48A8-977C-306AAE632F49Q38671679-FF7F5C5D-3BC6-4582-9535-3D412FA14E89Q39350422-EAB8E43F-5358-4E78-B3D5-A869DF838E94Q40106428-EDC46987-499F-4B2F-91B4-57CFB67AE600Q42361754-F69D368F-2C9C-49C8-ABF5-0C4E2DF25D1BQ47130457-97767668-67B2-4846-824A-01077CD7AE02Q48016716-720B45CF-992C-468F-A183-DEB50FC12CC9
P2860
Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Defining the in vivo phenotype ...... malaria: a modelling approach
@ast
Defining the in vivo phenotype ...... malaria: a modelling approach
@en
Defining the in vivo phenotype ...... malaria: a modelling approach
@nl
type
label
Defining the in vivo phenotype ...... malaria: a modelling approach
@ast
Defining the in vivo phenotype ...... malaria: a modelling approach
@en
Defining the in vivo phenotype ...... malaria: a modelling approach
@nl
prefLabel
Defining the in vivo phenotype ...... malaria: a modelling approach
@ast
Defining the in vivo phenotype ...... malaria: a modelling approach
@en
Defining the in vivo phenotype ...... malaria: a modelling approach
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Defining the in vivo phenotype ...... malaria: a modelling approach
@en
P2093
Delia Bethell
Elizabeth A Ashley
Ja Hser Wiladpai-ngern
Kamolrat Silamut
Lisa J White
Standwell Nkhoma
Tim Anderson
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001823
P407
P50
P577
2015-04-01T00:00:00Z